However, according to William Blair analysts, retatrutides tolerability profile could confine the drug to use in patients at the higher end of the BMI spectrum, while tirzepatide will continue to serve as the go-to medication, due to its balanced efficacy and tolerability profile. At the highest dose of retatrutide, 11.3% of participants discontinued treatment due to adverse effects
The Science Behind Sublingual Tirzepatide How Tirzepatide Works Tirzepatide mimics the effects of two incretin hormones, GIP and GLP-1, which play a crucial role in glucose metabolism
Retrieved from Gao, R., Tao, Y., Zhou, C., et al
Most compounds that target tumor metabolism (methotrexate, 5-fluorouracil) fail to distinguish between tumor tissue and rapidly differentiating epithelial tissue (skin, bone marrow), 4,322 whereas therapies targeting the specific amino acid dependence of tumor cells are cell-selective, such as leukemic blasts that are selectively dependent on Asn, the use of bacterial-derived ASNase in pediatric ALL has significantly improved the cure rate
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal studies report wide therapeutic window Known interactions Methyl-donor depletion theoretical with chronic dosing (NNMT methylates nicotinamide using SAM) Contraindications Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Not FDA-approved